Impact of Changes in Free Concentrations and Drug-Protein Binding on Drug Dosing Regimens in Special Populations and Disease States
- 2 June 2021
- journal article
- review article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 110 (10) , 3331-3344
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (1R15GM126510)
This publication has 52 references indexed in Scilit:
- The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumoniaClinical Interventions in Aging, 2013
- Pharmacodynamics of vancomycin in elderly patients aged 75 years or older with methicillin-resistant Staphylococcus aureus hospital-acquired pneumoniaClinical Interventions in Aging, 2013
- Pharmacologic prevention of venous thromboembolism in obese patientsJournal of Thrombosis and Thrombolysis, 2012
- Calculation of Normalized Drug Concentrations in the Presence of Altered Plasma Protein BindingClinical Pharmacokinetics, 2012
- Adult age andex vivoprotein binding of lorazepam, oxazepam and temazepam in healthy subjectsBritish Journal of Clinical Pharmacology, 2011
- Therapeutic Drug Monitoring During Pregnancy and Lactation: Thyroid Function Assessment in Pregnancy—Challenges and SolutionsTherapeutic Drug Monitoring, 2010
- Effect of Obesity on the Pharmacokinetics of Drugs in HumansClinical Pharmacokinetics, 2010
- Unbound Cephalothin Pharmacokinetics in Adult Burn Patients Are Related to the Elapsed Time after InjuryAntimicrobial Agents and Chemotherapy, 2009
- Pharmacokinetic Evaluation of Single-Dose Intravenous Daptomycin in Patients with Thermal Burn InjuryAntimicrobial Agents and Chemotherapy, 2008
- Plasma Protein Binding of Drugs in the ElderlyClinical Pharmacokinetics, 1987